摘要
目的:确定可以增强疾病管理的潜在生物标志物,并总结可用的免疫疗法以方便参考。方法:我们回顾了PubMed中GTNs免疫疗法的相关文献。结论:免疫疗法有望成为治愈耐多药妊娠滋养细胞瘤变患者的一种新的强大且低毒性的治疗方法。
Objective: To identify potential biomarkers that can enhance disease management and to summa-rize available immunotherapies for ease of reference. Methods: We reviewed the literature on GTNs immunotherapy in PubMed. Conclusion: Immunotherapy is expected to be a new powerful and low- toxicity treatment for the cure of multidrug-resistant gestational trophoblastoma patients.
出处
《临床医学进展》
2023年第9期15188-15193,共6页
Advances in Clinical Medicine
